124 related articles for article (PubMed ID: 36752377)
1. Identifying bioactive phytoconstituents as C-terminal Src kinase inhibitors: a virtual screening and molecular simulation approach.
Elfaki EM; Alhassan HH; Kamal M; Al-Enazi MM; Rub MA; Asiri AM; Ali M; Marwani HM; Alharethi SH; Alotaibi MM; Azum N
J Biomol Struct Dyn; 2023; 41(22):13415-13424. PubMed ID: 36752377
[TBL] [Abstract][Full Text] [Related]
2. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
[TBL] [Abstract][Full Text] [Related]
3. Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics.
Yang C; Alam A; Alhumaydhi FA; Khan MS; Alsagaby SA; Al Abdulmonem W; Hassan MI; Shamsi A; Bano B; Yadav DK
Molecules; 2022 May; 27(10):. PubMed ID: 35630545
[TBL] [Abstract][Full Text] [Related]
4. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development.
Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L
J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027
[TBL] [Abstract][Full Text] [Related]
5. CSK may be a potential prognostic biomarker reflecting the immune status of gastric cancer.
Yan X; Huan J
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):221-230. PubMed ID: 38235873
[TBL] [Abstract][Full Text] [Related]
6. C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.
Senda Y; Murata-Kamiya N; Hatakeyama M
Cancer Sci; 2016 Jul; 107(7):972-80. PubMed ID: 27116701
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new interaction mode between the Src homology 2 domain of C-terminal Src kinase (Csk) and Csk-binding protein/phosphoprotein associated with glycosphingolipid microdomains.
Tanaka H; Akagi K; Oneyama C; Tanaka M; Sasaki Y; Kanou T; Lee YH; Yokogawa D; Dobenecker MW; Nakagawa A; Okada M; Ikegami T
J Biol Chem; 2013 May; 288(21):15240-54. PubMed ID: 23548896
[TBL] [Abstract][Full Text] [Related]
8. Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach.
Alotaibi BS; Joshi J; Hasan MR; Khan MS; Alharethi SH; Mohammad T; Alhumaydhi FA; Elasbali AM; Hassan MI
J Biomol Struct Dyn; 2023; 41(14):6749-6758. PubMed ID: 35965440
[TBL] [Abstract][Full Text] [Related]
9. Csk αC Helix: A Computational Analysis of an Essential Region for Conformational Transitions.
Dias RVR; Ferreira CTA; Jennings PA; Whitford PC; Oliveira LC
J Phys Chem B; 2022 Dec; 126(50):10587-10596. PubMed ID: 36512419
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers.
Hakami MA; Alotaibi BS; Hazazi A; Shafie A; Alsaiari AA; Ashour AA; Anjum F
J Biomol Struct Dyn; 2024 Apr; 42(6):2965-2975. PubMed ID: 37184150
[TBL] [Abstract][Full Text] [Related]
11. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
[TBL] [Abstract][Full Text] [Related]
12. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).
Lee S; Ayrapetov MK; Kemble DJ; Parang K; Sun G
J Biol Chem; 2006 Mar; 281(12):8183-9. PubMed ID: 16439366
[TBL] [Abstract][Full Text] [Related]
13. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel
Elasbali AM; Al-Soud WA; Elfaki EM; Alanazi HH; Alharbi B; Alharethi SH; Anwer K; Mohammad T; Hassan MI
J Biomol Struct Dyn; 2023 Jul; ():1-13. PubMed ID: 37403288
[TBL] [Abstract][Full Text] [Related]
15. Early emergence of negative regulation of the tyrosine kinase Src by the C-terminal Src kinase.
Taskinen B; Ferrada E; Fowler DM
J Biol Chem; 2017 Nov; 292(45):18518-18529. PubMed ID: 28939764
[TBL] [Abstract][Full Text] [Related]
16. C-terminal Src kinase (Csk)-mediated phosphorylation of eukaryotic elongation factor 2 (eEF2) promotes proteolytic cleavage and nuclear translocation of eEF2.
Yao Q; Liu BQ; Li H; McGarrigle D; Xing BW; Zhou MT; Wang Z; Zhang JJ; Huang XY; Guo L
J Biol Chem; 2014 May; 289(18):12666-78. PubMed ID: 24648518
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Src and Csk nonreceptor tyrosine kinases in the filasterean Ministeria vibrans.
Schultheiss KP; Craddock BP; Suga H; Miller WT
Biochemistry; 2014 Mar; 53(8):1320-9. PubMed ID: 24520931
[TBL] [Abstract][Full Text] [Related]
18. Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.
Yeh WL; Shioda K; Coser KR; Rivizzigno D; McSweeney KR; Shioda T
PLoS One; 2013; 8(4):e60889. PubMed ID: 23593342
[TBL] [Abstract][Full Text] [Related]
19. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
20. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
